PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile mkhoury@uandes.cl.\', \'Cells for Cells and consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.\', \'M. Khoury and D.J. Weiss contributed equally as lead authors of the study.\', \'Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.\', \'Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.\', \'National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Brazil.\', \'Dept of Medicine, University of Vermont, Burlington, VT, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 200085810.1183/13993003.00858-2020
?:doi
?:hasPublicationType
?:journal
  • The European respiratory journal
is ?:pmid of
?:pmid
?:pmid
  • 32265310
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32265310>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32265310>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all